Interestingly, inhibition of AKT appeared to reduce PARP1 protein level and PAR level in both PDX tumor tissue and ovarian cancer cell lines (OVCAR8 and OVCA433), although detailed mechanism is unclear. Here, AKT1 is linked to ovarian carcinoma.